Genesys International Corporation Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.In terms of Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 ( SEBI Listing Regulations ), we wish to informthat the Board of Directors of the Company at its meeting held today i.e. onThursday, February 12, 2026, inter alia, considered and approved the following:1. Un-audited Financial Results (Standalone & Consolidated) for the third quarterand nine months ended December 31, 2025, along with Limited Review Reportof Statutory Auditors. Copies of following enclosed as Annexure-I:a. Un-audited Financial Results (Standalone & Consolidated) for the thirdquarter and nine months ended December 31, 2025.b. Limited Review Report of the Statutory Auditors on aforesaid results.
GENESYS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genesys International reported its Q3 FY26 (Oct–Dec 2025) unaudited results. Standalone revenue from operations grew to ₹6,651.43 lakhs from ₹5,992.12 lakhs in the previous quarter, but the nine-month standalone revenue slipped to ₹19,386.01 lakhs from ₹20,323.47 lakhs a year earlier. Standalone profit after tax for 9M FY26 fell sharply to ₹1,788.90 lakhs vs ₹4,666.29 lakhs in 9M FY25, partly due to a one-time exceptional charge of ₹509.62 lakhs tied to the new Labour Codes (gratuity and leave encashment remeasurement). On a consolidated basis, 9M PAT dropped to ₹2,007.78 lakhs from ₹3,710.63 lakhs, with the Middle East subsidiary continuing to drag (₹605.29 lakhs loss in 9M FY26). The auditor (MSKA & Associates) issued an unmodified (clean) limited review opinion.
Sharply lower year-on-year profits and an exceptional Labour Code charge are negatives for near-term earnings, though the ₹11,000 lakh QIP raised in May 2025 strengthens the balance sheet for growth investments. Investors should watch for stabilization of the Middle East subsidiary and clarity on use of QIP proceeds.